DOI QR코드

DOI QR Code

Corn silk extract improves cholesterol metabolism in C57BL/6J mouse fed high-fat diets

  • Received : 2016.04.11
  • Accepted : 2016.06.14
  • Published : 2016.10.01

Abstract

BACKGROUNG/OBJECTIVES: Corn silk (CS) extract contains large amounts of maysin, which is a major flavonoid in CS. However, studies regarding the effect of CS extract on cholesterol metabolism is limited. Therefore, the purpose of this study was to determine the effect of CS extract on cholesterol metabolism in C57BL/6J mouse fed high-fat diets. MATERIALS/METHODS: Normal-fat group fed 7% fat diet, high-fat (HF) group fed 25% fat diet, and high-fat with corn silk (HFCS) group were orally administered CS extract (100 mg/kg body weight) daily. Serum and hepatic levels of total lipids, triglycerides, and total cholesterol as well as serum free fatty acid, glucose, and insulin levels were determined. The mRNA expression levels of acyl-CoA: cholesterol acyltransferase (ACAT), cholesterol 7-alpha hydroxylase (CYP7A1), farnesoid X receptor (FXR), lecithin cholesterol acyltransferase (LCAT), low-density lipoprotein receptor, 3-hyroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase), adiponectin, leptin, and tumor necrosis factor ${\alpha}$ were determined. RESULTS: Oral administration of CS extract with HF improved serum glucose and insulin levels as well as attenuated HF-induced fatty liver. CS extracts significantly elevated mRNA expression levels of adipocytokines and reduced mRNA expression levels of HMG-CoA reductase, ACAT, and FXR. The mRNA expression levels of CYP7A1 and LCAT between the HF group and HFCS group were not statistically different. CONCLUSIONS: CS extract supplementation with a high-fat diet improves levels of adipocytokine secretion and glucose homeostasis. CS extract is also effective in decreasing the regulatory pool of hepatic cholesterol, in line with decreased blood and hepatic levels of cholesterol though modulation of mRNA expression levels of HMG-CoA reductase, ACAT, and FXR.

Keywords

References

  1. Koska J, Stefan N, Permana PA, Weyer C, Sonoda M, Bogardus C, Smith SR, Joanisse DR, Funahashi T, Krakoff J, Bunt JC. Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals. Am J Clin Nutr 2008;87:295-302. https://doi.org/10.1093/ajcn/87.2.295
  2. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett 2006;580:2917-21. https://doi.org/10.1016/j.febslet.2006.04.028
  3. Doan DD, Nguyen NH, Doan HK, Nguyen TL, Phan TS, van Dau N, Grabe M, Johansson R, Lindgren G, Stjernstrom NE. Studies on the individual and combined diuretic effects of four Vietnamese traditional herbal remedies (Zea mays, Imperata cylindrica, Plantago major and Orthosiphon stamineus). J Ethnopharmacol 1992;36:225-31. https://doi.org/10.1016/0378-8741(92)90048-V
  4. Hasanudin K, Hashim P, Mustafa S. Corn silk (Stigma maydis) in healthcare: a phytochemical and pharmacological review. Molecules 2012;17:9697-715. https://doi.org/10.3390/molecules17089697
  5. Kan A, Orhan I, Coksari G, Sener B. In-vitro neuroprotective properties of the Maydis stigma extracts from four corn varieties. Int J Food Sci Nutr 2012;63:1-4.
  6. Velazquez DV, Xavier HS, Batista JE, de Castro-Chaves C. Zea mays L. extracts modify glomerular function and potassium urinary excretion in conscious rats. Phytomedicine 2005;12:363-9. https://doi.org/10.1016/j.phymed.2003.12.010
  7. Zhao W, Yin Y, Yu Z, Liu J, Chen F. Comparison of anti-diabetic effects of polysaccharides from corn silk on normal and hyperglycemia rats. Int J Biol Macromol 2012;50:1133-7. https://doi.org/10.1016/j.ijbiomac.2012.02.004
  8. Farsi DA, Harris CS, Reid L, Bennett SA, Haddad PS, Martineau LC, Arnason JT. Inhibition of non-enzymatic glycation by silk extracts from a Mexican land race and modern inbred lines of maize (Zea mays). Phytother Res 2008;22:108-12. https://doi.org/10.1002/ptr.2275
  9. Suzuki R, Okada Y, Okuyama T. The favorable effect of style of Zea mays L. on streptozotocin induced diabetic nephropathy. Biol Pharm Bull 2005;28:919-20. https://doi.org/10.1248/bpb.28.919
  10. Guo J, Liu T, Han L, Liu Y. The effects of corn silk on glycaemic metabolism. Nutr Metab (Lond) 2009;6:47. https://doi.org/10.1186/1743-7075-6-47
  11. Maksimovic Z, Dobric S, Kovacevic N, Milovanovic Z. Diuretic activity of Maydis stigma extract in rats. Pharmazie 2004;59:967-71.
  12. Bai H, Hai C, Xi M, Liang X, Liu R. Protective effect of maize silks (Maydis stigma) ethanol extract on radiation-induced oxidative stress in mice. Plant Foods Hum Nutr 2010;65:271-6. https://doi.org/10.1007/s11130-010-0172-6
  13. Choi DJ, Kim SL, Choi JW, Park YI. Neuroprotective effects of corn silk maysin via inhibition of H2O2-induced apoptotic cell death in SK-N-MC cells. Life Sci 2014;109:57-64. https://doi.org/10.1016/j.lfs.2014.05.020
  14. Maksimovic Z, Malencic D, Kovacevic N. Polyphenol contents and antioxidant activity of Maydis stigma extracts. Bioresour Technol 2005;96:873-7. https://doi.org/10.1016/j.biortech.2004.09.006
  15. Kim SL, Kim MJ, Lee YY, Jung GH, Son BY, Lee JS, Kwon YU, Park YI. Isolation and identification of flavonoids from corn silk. Korean J Crop Sci 2014;59:435-44. https://doi.org/10.7740/kjcs.2014.59.4.435
  16. Waiss AC Jr, Chan BG, Elliger CA, Wiseman BR, McMillian WW, Widstrom NW, Zuber MS, Keaster AJ. Maysin, a flavone glycoside from corn silks with antibiotic activity toward corn earworm. J Econ Entomol 1979;72:256-8. https://doi.org/10.1093/jee/72.2.256
  17. Lee EA, Byrne PF, McMullen MD, Snook ME, Wiseman BR, Widstrom NW, Coe EH. Genetic mechanisms underlying apimaysin and maysin synthesis and corn earworm antibiosis in maize (Zea mays L.). Genetics 1998;149:1997-2006.
  18. Jeong HW, Lee JW, Kim WS, Choe SS, Kim KH, Park HS, Shin HJ, Lee GY, Shin D, Lee H, Lee JH, Choi EB, Lee HK, Chung H, Park SB, Park KS, Kim HS, Ro S, Kim JB. A newly identified CG301269 improves lipid and glucose metabolism without body weight gain through activation of peroxisome proliferator-activated receptor alpha and gamma. Diabetes 2011;60:496-506. https://doi.org/10.2337/db09-1145
  19. Min OJ, Sharma BR, Park CM, Rhyu DY. Effect of myadis stigma water extract on adipogenesis and blood glucose in 3T3-L1 adipocytes and db/db mice. Korean J Pharmacogn 2011;42:201-8.
  20. Schreyer SA, Wilson DL, LeBoeuf RC. C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. Atherosclerosis 1998;136:17-24. https://doi.org/10.1016/S0021-9150(97)00165-2
  21. Reeves PG. Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr 1997;127:838S-841S. https://doi.org/10.1093/jn/127.5.838S
  22. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957;226:497-509.
  23. Ha AW, Kim WK. The effect of fucoxanthin rich power on the lipid metabolism in rats with a high fat diet. Nutr Res Pract 2013;7:287-93. https://doi.org/10.4162/nrp.2013.7.4.287
  24. Dai W, Wang K, Zheng X, Chen X, Zhang W, Zhang Y, Hou J, Liu L. High fat plus high cholesterol diet lead to hepatic steatosis in zebrafish larvae: a novel model for screening anti-hepatic steatosis drugs. Nutr Metab (Lond) 2015;12:42. https://doi.org/10.1186/s12986-015-0036-z
  25. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006;116:1784-92. https://doi.org/10.1172/JCI29126
  26. Li Y, Qin G, Liu J, Mao L, Zhang Z, Shang J. Adipose tissue regulates hepatic cholesterol metabolism via adiponectin. Life Sci 2014;118:27-33. https://doi.org/10.1016/j.lfs.2014.10.003
  27. Liu Q, Yuan B, Lo KA, Patterson HC, Sun Y, Lodish HF. Adiponectin regulates expression of hepatic genes critical for glucose and lipid metabolism. Proc Natl Acad Sci U S A 2012;109:14568-73. https://doi.org/10.1073/pnas.1211611109
  28. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, Uchida S, Ito Y, Takakuwa K, Matsui J, Takata M, Eto K, Terauchi Y, Komeda K, Tsunoda M, Murakami K, Ohnishi Y, Naitoh T, Yamamura K, Ueyama Y, Froguel P, Kimura S, Nagai R, Kadowaki T. Globular adiponectin protected ob/ob mice from diabetes and ApoEdeficient mice from atherosclerosis. J Biol Chem 2003;278:2461-8. https://doi.org/10.1074/jbc.M209033200
  29. DeBose-Boyd RA. Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase. Cell Res 2008;18:609-21. https://doi.org/10.1038/cr.2008.61
  30. Krause BR, Pape ME, Kieft K, Auerbach B, Bisgaier CL, Homan R, Newton RS. ACAT inhibition decreases LDL cholesterol in rabbits fed a cholesterol-free diet. Marked changes in LDL cholesterol without changes in LDL receptor mRNA abundance. Arterioscler Thromb 1994;14:598-604. https://doi.org/10.1161/01.ATV.14.4.598
  31. Davignon J, Montigny M, Dufour R. HMG-CoA reductase inhibitors: a look back and a look ahead. Can J Cardiol 1992;8:843-64.
  32. Burnett JR, Wilcox LJ, Telford DE, Kleinstiver SJ, Barrett PH, Newton RS, Huff MW. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs. Arterioscler Thromb Vasc Biol 1997;17:2589-600. https://doi.org/10.1161/01.ATV.17.11.2589
  33. Burnett JR, Wilcox LJ, Telford DE, Kleinstiver SJ, Barrett PH, Newton RS, Huff MW. Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs. J Lipid Res 1999;40:1317-27.
  34. Llaverías G, Laguna JC, Alegret M. Pharmacology of the ACAT inhibitor avasimibe (CI-1011). Cardiovasc Drug Rev 2003;21:33-50.
  35. Evans MJ, Mahaney PE, Borges-Marcucci L, Lai K, Wang S, Krueger JA, Gardell SJ, Huard C, Martinez R, Vlasuk GP, Harnish DC. A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia. Am J Physiol Gastrointest Liver Physiol 2009;296:G543-52. https://doi.org/10.1152/ajpgi.90585.2008
  36. Mencarelli A, Fiorucci S. FXR an emerging therapeutic target for the treatment of atherosclerosis. J Cell Mol Med 2010;14:79-92. https://doi.org/10.1111/j.1582-4934.2009.00997.x

Cited by

  1. Corn silk extract improves benign prostatic hyperplasia in experimental rat model vol.11, pp.5, 2017, https://doi.org/10.4162/nrp.2017.11.5.373
  2. female inflorescences (maize silks) from Mexican maize landraces vol.16, pp.1, 2018, https://doi.org/10.1080/19476337.2017.1343866
  3. Rapid discovery and global characterization of multiple components in corn silk using a multivariate data processing approach based on UHPLC coupled with electrospray ionization/quadrupole time-of-flight mass spectrometry vol.41, pp.21, 2018, https://doi.org/10.1002/jssc.201800605
  4. Acute and Subacute Toxicity Evaluation of Corn Silk Extract vol.23, pp.1, 2018, https://doi.org/10.3746/pnf.2018.23.1.70
  5. Inhibitory effect of saccharides and phenolic compounds from maize silks on intestinal α‐glucosidases vol.43, pp.7, 2016, https://doi.org/10.1111/jfbc.12896
  6. Corn silk decoction for blood lipid in patients with angina pectoris: A systematic review and meta‐analysis vol.33, pp.11, 2016, https://doi.org/10.1002/ptr.6474
  7. Corn silk extracts did not alter the adiposity and underlying substrate utilization in high-fat diet-induced obese C57BL/6 mice vol.52, pp.2, 2016, https://doi.org/10.9721/kjfst.2020.52.2.144
  8. Use of Corn Silk Meal in Broiler Diet: Effect on Growth Performance, Blood Biochemistry, Immunological Responses, and Growth-Related Gene Expression vol.11, pp.4, 2021, https://doi.org/10.3390/ani11041170
  9. Lemon Balm and Corn Silk Extracts Mitigate High-Fat Diet-Induced Obesity in Mice vol.10, pp.12, 2021, https://doi.org/10.3390/antiox10122015